Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
EPIDYOLEX Lös 100 mg/ml Fl 100 ml
Drug
Epidyolex, Lösung zum Einnehmen
Zusatztherapie bei Krampfanfällen bei Patienten ab 2 Jahren mit Lennox-Gastaut-Syndrom (LGS), Dravet-Syndrom (DS) oder der Tuberösen Sklerose (TSC)
01.07.1. – simple antiepileptics
HAM – Human medicine
LSOR – Oral solution
S – synthetic products for human use
A – Dispensed once only on prescription by a physician or veterinarian (A)
Z – approved
2/10/2021
2/9/2026
Dosage strength
Epidyolex 100 mg / 1 ml, Lösung zum Einnehmen
Zusatztherapie bei Krampfanfällen bei Patienten ab 2 Jahren mit Lennox-Gastaut-Syndrom (LGS), Dravet-Syndrom (DS) oder der Tuberösen Sklerose (TSC)
01
Z – approved
Package
7680675900015
No information made available
A/R – Authorised / referenced
100 ml
001
Z – approved
Declaration
Component
100 mg cannabidiolum
79 mg ethanolum anhydricum
sucralosum
aromatica
0.3 µg alcohol benzylicus
736 mg sesami oleum raffinatum
sucralosum
aromatica
0.3 µg alcohol benzylicus
736 mg sesami oleum raffinatum
Authorisation holder
7601001383715
DRAC AG
Hauptgasse 29
3280 Murten (FR)
Hauptgasse 29
3280 Murten (FR)
Date of revision of the text
9/1/2022
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.